Compass Therapeutics, Inc. (CMPX) SEC Filings — 2024
18 SEC filings for Compass Therapeutics, Inc. (CMPX) in 2024.
Filings
- Compass Therapeutics Appoints New Chief Medical Officer — 8-K · Dec 10, 2024
- Compass Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Compass Therapeutics Q3 2024 Update: Key Agreements Highlighted — 10-Q · Nov 12, 2024
- Compass Therapeutics Q2 2024 Update — 10-Q · Aug 12, 2024
- Compass Therapeutics, Inc. SC 13G Filing — SC 13G · Aug 2, 2024
- Compass Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 17, 2024
- Compass Therapeutics Files Proxy Materials — DEFA14A · May 29, 2024
- Compass Therapeutics Appoints New CMO, Elects Director — 8-K · May 28, 2024
- Compass Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Compass Therapeutics Announces 2024 Annual Meeting of Stockholders on June 13, 2024 — DEF 14A · Apr 29, 2024
- Compass Therapeutics Files 8-K — 8-K · Apr 25, 2024
- OrbiMed Adjusts Stake in Compass Therapeutics — SC 13D/A · Mar 22, 2024
- Compass Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- FMR LLC & Abigail Johnson Trim Compass Therapeutics Stake to 3.57% — SC 13G/A · Feb 9, 2024
- Adage Capital Partners Reports 8.0% Stake in Compass Therapeutics — SC 13G/A · Feb 7, 2024
- Janus Henderson Discloses 6.00% Stake in Compass Therapeutics — SC 13G · Feb 1, 2024
- Compass Therapeutics Reports Executive Changes & Compensation on Jan 8 — 8-K · Jan 9, 2024
- Compass Therapeutics Files 8-K on Financial Condition & Operations — 8-K · Jan 5, 2024